How to Verify an FDA 510(k) Clearance: A Distributor's Guide to Checking a K Number, Reading the Clearance Record, and Telling Clearance, Registration and Listing Apart

This guide is written for international medical-device distributors, importers, hospital procurement engineers, tender evaluation committees, and private-label OEM buyers evaluating suppliers—particularly manufacturers in China and Asia-Pacific—quoting FDA compliance for sterile single-use devices, including disposable circumcision staplers, endovenous laser fibers, negative pressure wound therapy (NPWT) consumables, and sterile procedure kits.

When a supplier claims its device is 'FDA cleared' or 'FDA approved', distributors face a severe commercial and legal risk: committing working capital, importing inventory, or submitting tender bids based on invalid, expired, misattributed, or mischaracterized documentation. In the United States, commercial marketing of most Class II medical devices requires substantial equivalence clearance under section 513(i)(1)(A) of the Federal Food, Drug, and Cosmetic (FD&C) Act¹. This guide delivers a practical, five-check verification workflow to confirm marketing authorization with primary FDA databases.

The Five-Check Verification Rule: From Static PDF to Live Public Record

In international medical-device trade, a PDF is not the record. Scanned 'clearance letters', altered decision notices, and ornamental wall certificates are easily fabricated or misapplied across unrelated device lines. The cornerstone of US regulatory due diligence is simple: every genuine 510(k) clearance exists as a publicly queryable electronic record in the FDA's databases². Verifying a claim requires five disciplined steps:

1. Step 1: Retrieve the K Number & Query the 510(k) Database. Demand the specific 510(k) number (e.g., K261701) from the supplier and search it directly in the FDA Premarket Notification Database. Confirm the record is live, shows a decision of 'Substantially Equivalent' (SE), and provides a link to the official 510(k) Summary.
2. Step 2: Execute the Five-Field Match. Reconcile five core data points between the supplier's commercial quotation and the FDA database: (a) 510(k) Number, (b) Device Name and covered model numbers, (c) Applicant of Record, (d) 3-letter Product Code, and (e) 21 CFR Regulation Number.
3. Step 3: Disambiguate Registration from Clearance. Verify whether the supplier is offering a 510(k) clearance or merely an Establishment Registration Number / Facility Establishment Identifier (FEI). As the FDA affirms, establishment registration is an inventory tool that does not denote product approval or legal marketing authorization.
4. Step 4: Check for Exemption or De Novo Pathways. If no 510(k) record appears, check the FDA Product Code Classification Database to confirm whether the device type is 510(k)-exempt (as are most Class I and some Class II devices) or governed by a De Novo grant (DEN number) rather than a traditional 510(k).
5. Step 5: Bind the Regulatory Evidence in the Supply Agreement. Require certified copies of the clearance letter and current 510(k) Summary, mandate immediate notification of design or manufacturing changes that could trigger a new 510(k) submission, and establish an annual audit of the supplier's October–December registration status.

This workflow complements the document-verification frameworks established across our other core jurisdictions. If you are qualifying suppliers across international markets, consult our companion guides on how to verify a Chinese supplier's NMPA registration certificate and how to verify a CE certificate and its notified body under EU MDR 2017/745. For manufacturers and distributors planning US submissions, our analysis of US 510(k) pathway evidence for disposable circumcision devices details dossier preparation and predicate selection.

What a Real 510(k) Clearance Looks Like: Reading the Public Database Record

When you execute a query in the FDA Releasable 510(k) Database, the search interface returns a structured record detailing the legal parameters of the marketing authorization². Understanding how to interpret each field is essential to identify scope limitations or unauthorized transfers.

Field-by-Field Breakdown of the Releasable 510(k) Database

The public database record contains thirteen distinct data fields defined by the Center for Devices and Radiological Health (CDRH)². The table below outlines each field, its verification significance, and what constitutes a pass or red flag during due diligence:

FDA Decision Letters vs. 510(k) Summaries: What to Request from Your Supplier

When auditing a supplier's marketing dossier, distributors should distinguish between the FDA Clearance Letter and the 510(k) Summary. The clearance letter is a formal administrative notice issued by CDRH stating that the device has been determined to be substantially equivalent to legally marketed predicate devices under section 513(i)(1)(A) of the FD&C Act¹. It identifies the K number, trade name, regulation number, product code, and regulatory class.

The 510(k) Summary (mandated under 21 CFR 807.92)¹⁶, however, is the technical core of the clearance. It contains: (1) a detailed description of device construction, materials, and physical dimensions; (2) the exact intended use and indications for use statement; (3) technological comparison against the named predicate device; and (4) summaries of non-clinical bench testing (biocompatibility, sterilization validation, electrical safety, mechanical endurance) and clinical data where applicable. If the public database record displays 'SUMMARY', the PDF can be downloaded directly from FDA servers. If it displays 'STATEMENT', the applicant has certified under 21 CFR 807.93 that it will provide a duplicate of the submission's safety-and-effectiveness information within 30 days of a written request¹⁶ — the technical content is still obtainable, but from the applicant, not from FDA.

Third-Party Review Program and the Mandatory eSTAR Era

Two operational factors shape modern 510(k) clearances. First, under the FDA Third Party Review Program (section 523 of the FD&C Act)¹⁵, accredited third-party organizations review eligible low-to-moderate-risk 510(k) submissions to compress review timelines. However, the third party never clears the device; it transmits its recommendation to CDRH, and the FDA alone makes the final substantial equivalence determination and issues the clearance letter.

Second, since 1 October 2023, the FDA has mandated the use of eSTAR (electronic Submission Template And Resource) for all 510(k) submissions¹². The standardized eSTAR structure has eliminated informal paper submissions and accelerated screening. Under MDUFA V, the FY2026 standard 510(k) user fee is set at USD 26,067 (for the period 1 October 2025 through 30 September 2026)¹³. As MDUFA V approaches its 30 September 2027 expiration, negotiations for MDUFA VI are underway following formal Federal Register notices and public stakeholder meetings held in August 2026¹⁴.

The Five-Field Matching Workflow: Reconciling Quotations Against FDA Records

Holding a genuine K number is insufficient if the clearance belongs to a different device or manufacturer. Distributors must execute a systematic 'five-field match' between the commercial quotation, product specification sheet, and the FDA public database record.

Reconciling Device Name, Applicant, Codes, and Regulations

Every discrepancy between a commercial offer and a public regulatory record must be accounted for before issuing a purchase order or signing an exclusive distribution agreement. The matching grid below establishes the standard evaluation protocol:

Applicant of Record vs. Physical Manufacturer: Deciphering US Agents and Distributors

A frequent source of confusion during due diligence is an applicant-name mismatch. In the FDA regulatory scheme, the 'Applicant' is the legal submitter of the 510(k), which may be the manufacturing facility, an offshore parent company, a US-based regulatory consulting firm acting as the US Agent, an initial importer, or a private-label distributor. An applicant-name mismatch is not automatic proof of fraud; it is a trigger for documented clarification.

Crucially, whoever holds the 510(k) clearance controls the US marketing authorization. If a Chinese contract manufacturer produces a device cleared under a US distributor's 510(k), the factory cannot legally authorize other distributors to sell that device under that K number. Conversely, if the foreign manufacturer holds the clearance, it can supply multiple distributors, provided each distributor is listed or acts as an initial importer. For detailed guidance on structuring OEM relationships, see our medical device contract manufacturing evidence checklist.

Where Do Model Numbers Live? Record Titles, 510(k) Summaries, and GUDID

In many 510(k) clearances, the 'Device Name' in the public database contains only a broad family trade name rather than listing every specific SKU or catheter diameter. Distributors seeking to confirm that a specific catalog model (e.g., a 400 µm radial fiber vs. a 600 µm radial fiber) is cleared must inspect two secondary sources:

• The 510(k) Summary PDF: Section 3 ('Device Description') typically lists all covered model variants, dimensional ranges, connector configurations, and accessory components.
• AccessGUDID (Global UDI Database): Under FDA UDI regulations (21 CFR 830), medical devices distributed in the US must have their Primary Device Identifier (DI) indexed in GUDID¹¹. Searching AccessGUDID by brand name or model number confirms the exact commercial package configuration and links it to the governing K number. Consult our guide on UDI requirements for private-label and OEM devices for implementation details.

Worked Example: Product Code GEX (Powered Laser Surgical Instruments)

To demonstrate how the five-field match operates in practice, consider Product Code GEX (Powered Laser Surgical Instrument, regulated under 21 CFR 878.4810, Class II, 510(k)-required). This code covers a broad family of powered surgical lasers — consoles, aesthetic and dermatologic systems, and single-use delivery fibers used in endovenous laser ablation (EVLA) and proctology⁶.

Analysis of the openFDA 510(k) bulk dataset (snapshot 24 July 2026) reveals that Product Code GEX encompasses 2,868 clearances granted to 788 distinct applicants since 1978⁷. Among these, 77 China-based applicants have obtained 169 clearances. In 2026 through mid-June alone, 33 GEX clearances were issued, illustrating an active and verifiable flow of China-to-US laser technology.

Recent database entries provide concrete examples of how device names and model numbers appear in public records. On 18 June 2026, Micro-Energy Medical Technology Co., Ltd. obtained clearance K261701 for its Hemolase Fiber under GEX. Notably, the public database title explicitly incorporates four model numbers in parentheses: Hemolase Fiber (Hemo-R-0.40-2.5/Hemo-R-0.60-2.5/Hemo-R-0.40-1.8/Hemo-R-0.60-1.8). This represents a hemorrhoid-application disposable radial fiber. Similarly, on 4 June 2026, Beijing Sano Laser S&T Development Co., Ltd. obtained clearance K260690 for its LumiGlam Laser System (SHE-LSP601-3) under Traditional 510(k) review⁷. For buyers sourcing vascular fibers, our 1470 nm radial fiber specification and RFQ guide outlines how to evaluate core concentricity and connector compatibility alongside 510(k) status.

The Registration-Versus-Clearance Trap: What FEI Numbers, Listing Records, and Export Certificates Actually Prove

The single most pervasive compliance trap encountered by international distributors is conflating an FDA Establishment Registration Number or Facility Establishment Identifier (FEI) with premarket device clearance. Thousands of suppliers display registration numbers on promotional materials as 'proof of FDA approval'—a claim the FDA actively repudiates.

“Mere registration of an establishment or listing of a drug or device does not denote approval of the establishment, the drug or device, or other drugs or devices of the establishment, nor does it mean that a product may be legally marketed.”— U.S. Food and Drug Administration, Consumer Update: Is It Really 'FDA Approved'?, Content Current as of 4 May 2026

Quantifying the Gap: 25,405 Registered Facilities vs. 34,507 Cleared Applicants

The scale of the registration-versus-clearance gap is underscored by empirical analysis of openFDA datasets (snapshot 24 July 2026)⁷, ⁸. The FDA Registration & Listing database contains 419,651 establishment-product listing records representing 25,405 distinct registered establishments (FEIs) worldwide — a role-inclusive count that covers manufacturers alongside contract manufacturers, specification developers, repackagers/relabelers, foreign exporters, and initial importers. In contrast, the entire 510(k) database contains 175,559 clearances issued to 34,507 distinct applicants across its nearly 50-year history.

For China-based suppliers specifically, the denominator gap is striking: there are 4,957 distinct China-located registered establishments in the Registration & Listing database, but only 2,261 distinct China-based applicants have ever obtained a 510(k) clearance (holding 5,589 clearances total)⁷, ⁸. There are more than twice as many China-located registered establishments as there have ever been China-based applicants who obtained any 510(k). A supplier can hold a perfectly valid FDA registration number and FEI while possessing zero legal authority to market a Class II sterile device in the United States.

No Such Thing as an 'FDA Registration Certificate'

Distributors are frequently presented with framed PDFs titled 'Official FDA Registration Certificate' complete with American flags, eagle emblems, and gold seals. The FDA does not issue registration certificates. As CDRH officially warns on its Registration & Listing database portal:

“Registration of a device establishment, assignment of a registration number, or listing of a medical device does not in any way denote approval of the establishment or its products by FDA.”— FDA Establishment Registration & Device Listing Database, Search Portal Notice, Updated 17 August 2026

Any 'registration certificate' presented by a supplier is an unofficial commercial document generated by a private registrar or US Agent: FDA states plainly that it 'does not issue device registration certificates' and that registered firms 'do not receive a certificate from the FDA'²⁰. The agency has even published an example of a misleading certificate that borrows the FDA logo, noting that firms displaying such certificates to imply FDA review or approval misbrand the device in violation of the FD&C Act — a major compliance red flag²⁰.

The Annual Registration Renewal Cycle (21 CFR 807.22)

Under 21 CFR 807.22(b)(1), all medical device establishments must renew their registration annually between October 1 and December 31 for the upcoming fiscal year⁵. Device listing information must also be verified and confirmed during this window. If a supplier fails to pay its annual establishment user fee or confirm its listings by December 31, its registration is not renewed for the new fiscal year — and a device manufactured in an establishment without an active registration is misbranded under section 502(o) of the FD&C Act¹⁹.

The public Registration & Listing database updates on a weekly cycle (generally completed by Monday evening)³. When checking a newly registered facility, allow up to one week for new entries or updates to propagate to public search results.

CDRH Export Certificates (CFG) and FECV Validation

Suppliers sometimes furnish an FDA 'Certificate to Foreign Government' (CFG) or 'Certificate of Exportability' as evidence of domestic US clearance. A CFG is an official CDRH document issued for devices that meet applicable US marketing requirements; the certificates that actually cite FD&C Act sections 801(e)(1) or 802 are the separate Certificates of Exportability, which cover devices that may not be legally marketed in the United States but satisfy export conditions¹⁸.

Distributors can verify genuine export certificates using the public FURLS Export Certificate Validator (FECV) (access.fda.gov/fecv/CDRH) via the URL or QR code printed on each certificate ¹⁰. FDA has issued device export certificates as electronic PDFs since January 2, 2024, and the legacy CECV database that verified pre-2024 paper certificates remained active only until January 2, 2026 ¹⁰. However, remember the critical distinction: a CFG documents the device's US marketing status for foreign-government purposes at the time of issuance; it is not a 510(k) clearance letter and does not replace the requirement to verify the underlying K number.

When No 510(k) Should Exist: Exempt Class I/II Devices, De Novo Grants, and PMA Approvals

Failing to find a 510(k) record does not automatically indicate non-compliance or fraud. Under the US statutory framework, certain device categories are legally marketed without a 510(k), while novel technologies enter through alternative pathways.

Navigating the Product Code Classification Database

Before rejecting a supplier whose device lacks a 510(k), query the FDA Product Code Classification Database (fda.gov)⁶. This database catalogues over 7,000 device product codes, defining risk class (Class I, II, or III), governing 21 CFR regulation number, and specific premarket submission requirements.

Analysis of the openFDA classification export (snapshot 24 July 2026) shows 7,084 total product codes. Of these, 3,213 codes require 510(k) premarket notification, while 2,638 codes are 510(k)-exempt¹⁷. The remainder are Class III PMA codes, Humanitarian Device Exemptions, enforcement-discretion codes, and codes not yet classified.

Exempt Class I and Class II Devices: General Controls without Premarket Notification

Most Class I devices (e.g., manual surgical instruments, basic wound bandages, simple examination gloves) and some Class II device types are exempt from 510(k) premarket notification by regulation — 484 of the 2,638 exempt product codes in the July 2026 openFDA export are Class II¹⁷. For an exempt device, no 510(k) record exists or should exist.

However, exempt status does not mean unregulated. Manufacturers of exempt devices must still comply with General Controls: (1) annual establishment registration and device listing (21 CFR 807); (2) Current Good Manufacturing Practice / Quality System Regulation (21 CFR 820 / QMSR); (3) labeling requirements (21 CFR 801); and (4) Medical Device Reporting (21 CFR 803)⁴. Furthermore, under the 'limitations on exemptions' provisions (e.g., 21 CFR 878.9), an otherwise exempt device loses its exemption and requires a 510(k) if it is supplied sterile, possesses measuring functions, or introduces a novel intended use.

A notable counter-example published in our previous research involves circumcision staplers: while the FDA established a dedicated product code QQR (Circumcision Device With Stapler, Class II, 21 CFR 884.4530), the openFDA database reveals zero clearances have ever been issued under QQR. Instead, the 32 historical circumcision-device clearances sit under older manual-instrument codes — HFX (circumcision clamp), FHG (circumcision bell), and FHJ (circumcision shield) — plus one 1993 circumcision tray identified by device name under HFK⁷. In that category, an absent clearance under the modern product code reflects regulatory classification history rather than non-compliance.

De Novo Marketing Authorization: Novel Devices with No Predicate

When a novel medical device is low-to-moderate risk but has no legally marketed predicate device, it cannot enter through the 510(k) pathway. Under section 513(f)(2) of the FD&C Act, the manufacturer submits a De Novo request⁹. If granted, the FDA classifies the device into Class I or Class II, creates a new product code and regulation, and issues a marketing authorization grant.

De Novo authorizations are identified by a DEN number rather than a K number and are indexed in the public FDA De Novo Database (accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/denovo.cfm)⁹. Once a De Novo grant is published, that device can serve as a predicate for future 510(k) submissions.

Red-Flag Decision Matrix: Deal-Breakers vs. Clarification Triggers

During distributor due diligence, compliance discrepancies range from critical fraud indicators to benign administrative artifacts. The matrix below categorizes common findings into definitive deal-breakers versus issues requiring documented clarification:

Distribution Agreement Terms and Ongoing Re-Verification Schedule

Regulatory due diligence does not end with signing a purchase order. Importers and distributors share post-market compliance responsibilities under US law. Distribution and OEM supply contracts should incorporate specific covenants to preserve legal marketing authorization throughout the product lifecycle.

Key Regulatory Clauses for US Distribution Agreements

When drafting or negotiating international supply contracts for the US market, incorporate the following six protective clauses:

1. Provision of Complete Regulatory Records: Supplier must furnish certified true copies of the original FDA 510(k) Clearance Letter, the complete 510(k) Summary, and the current Device Listing confirmation prior to initial shipment.
2. Applicant of Record & Facility Identification: The agreement must explicitly declare the legal holder of the 510(k), the named US Agent, and the specific physical manufacturing facility's FEI number.
3. Annual Registration Maintenance Covenant: Supplier covenants to renew its FDA establishment registration and maintain active device listings annually during the October 1 – December 31 window under 21 CFR 807.22, providing proof of payment and listing confirmation by January 15.
4. Mandatory Design & Process Change Notification: Under 21 CFR 807.81(a)(3), changes to device design, materials, sterilization method, or intended use that could significantly affect safety or effectiveness require a new 510(k). The agreement must require 90 days' advance notice of any planned modifications and prohibit shipment of modified devices until regulatory clearance is established.
5. UDI & GUDID Compliance Warranty: Supplier warrants that all distributed units bear compliant Unique Device Identification (UDI) carriers under 21 CFR 830 and that all Device Identifiers are actively published in AccessGUDID.
6. Adverse Event & Recall Cooperation: Both parties agree to establish standard operating procedures for Medical Device Reporting (MDR, 21 CFR 803) and recall execution (21 CFR 7 / 806), ensuring prompt cross-notification within 48 hours of any reportable adverse event.

Where VEMERIX Fits — and Where Due Diligence Still Begins

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery, and perioperative care.

In alignment with the rigorous verification standards outlined in this guide, VEMERIX maintains absolute transparency regarding its regulatory standing: our core product lines—including disposable circumcision staplers, 1470 nm medical laser fibers, NPWT dressings, and scar care products—are fully registered with the National Medical Products Administration (NMPA) in China and hold European CE marking where applicable (such as our CE-marked Auto-Circumcision Ring). We do not claim FDA 510(k) clearances for product lines where US premarket authorizations have not yet been granted.

International distributors, hospital procurement teams, and OEM partners evaluating registration dossiers, CE technical packs, or contract manufacturing capabilities can request official regulatory roadmaps and documentation packs directly via our Downloads Portal or by contacting our regulatory affairs team through our Contact Page.

Frequently Asked Questions (FAQ)

Is there a standard 510(k) number format I can check before searching?

Yes, as an observed empirical convention across 175,559 records in the openFDA database, 510(k) numbers follow a 7-character structure: the prefix 'K', followed by a two-digit fiscal year of receipt (e.g., '26' for FY2026: 1 October 2025 – 30 September 2026), followed by a 4-digit sequential receipt number (e.g., K261701). Analysis confirms that 171,608 records are consistent with this pattern. While this is an observed administrative regularity rather than a codified statutory rule, any number with year digits that postdate the decision date or that diverges from K###### warrants immediate verification.

My supplier sent an 'FDA registration certificate' with a gold seal — is that a real FDA document?

No. FDA states plainly that it 'does not issue device registration certificates' to medical device facilities²⁰. Framed certificates with seals and emblems are created by private consulting agencies as receipts for registration filing services. The FDA explicitly warns that registration 'does not in any way denote approval of the establishment or its products.' To verify registration, search the supplier's name or FEI directly in the public FDA Establishment Registration & Device Listing database.

Is FDA 510(k) clearance the same as FDA approval?

No. Under US law, 'FDA Clearance' applies to Class II devices that demonstrate substantial equivalence to a legally marketed predicate device under the 510(k) pathway. 'FDA Approval' is legally reserved for high-risk Class III devices (e.g., pacemakers, heart valves) evaluated through the rigorous Premarket Approval (PMA) pathway involving direct clinical evidence. Describing a 510(k)-cleared Class II device as 'FDA Approved' misstates its regulatory status — the clearest single sign that a marketing team, not a regulatory affairs team, wrote the claim.

The 510(k) record names a US agent or distributor, not my supplier — is the clearance still valid?

The clearance may be completely valid, but you must establish the legal relationship between the applicant of record and the manufacturer. Foreign manufacturers frequently engage US Agents or master distributors to submit 510(k) applications. However, the applicant of record legally owns the clearance. Request a formal tripartite agreement or authorization letter confirming that the manufacturer is authorized to produce the device under that specific K number.

Are all 510(k) submissions public, including pending ones?

No. Only cleared submissions appear in the public 510(k) database, so a 'pending' application has no public record to check. Under 21 CFR 807.95, FDA's disclosure of even a submission's existence before marketing is limited, and a submission's contents are not published¹⁶. A supplier therefore cannot provide a 'pending 510(k) database record.' If a supplier claims an application is under review, the device cannot be legally marketed or distributed in the US until the formal clearance letter is issued and the record appears.

My supplier's device is Class I and 'FDA registered' only — what should I check instead of a 510(k)?

For 510(k)-exempt Class I devices (e.g., non-sterile surgical scissors, manual examination instruments), verify three elements: (1) verify the Product Code in the FDA Classification Database to confirm it is classified as Class I 510(k)-exempt; (2) verify the supplier's active listing in the Establishment Registration & Device Listing database; and (3) confirm the device meets the limitations on exemptions (it must not be sterile, measuring, or novel in design).

Can the distributor or OEM hold the 510(k) instead of the manufacturer?

Yes. A private-label distributor or OEM partner may submit and hold its own 510(k) clearance, listing the third-party factory as a contract manufacturer. In this model, the distributor owns the marketing authorization and can change manufacturing partners by submitting a Special or Traditional 510(k) modification. Conversely, if the manufacturer holds the 510(k), the distributor acts as an initial importer or distributor without owning the underlying regulatory asset.

Does an FDA export certificate (CFG) prove the device is cleared for sale in the US?

A Certificate to Foreign Government (CFG) certifies that the device meets US regulatory requirements (including 510(k) clearance or exemption) and is legally marketable in the United States¹⁸. However, a Certificate of Exportability (issued under section 801(e) or 802) certifies devices manufactured in the US for export only that may not meet domestic US requirements¹⁸. Always verify the certificate in FDA's FURLS Export Certificate Validator (FECV) — remembering that the legacy CECV paper-certificate database was retired on January 2, 2026 — and check the underlying 510(k) number directly.